Medical Image Interpretation & Assessment
RadPharm understands the crucial role board-certified physicians play in the imaging segment of clinical trials. In today’s drug development environment, regulation is stringent and resources can be scarce; RadPharm employs only full-time board-certified radiologists, nuclear medicine physicians and medical oncologists. We deliver on the promise of credible medical imaging data within tight timelines and defined budget parameters.
RadPharm provides centralized, independent, unbiased interpretation of medical images for clinical trials, supported by medical and scientific expertise and advanced technology. Our staff physicians work with you from project onset through to submission and data archival.
 We provide:
- Protocol and study design consultation
- Charter development
- Image interpretation and response assessment
- Lesion selection
- Lesion measurement
- Regulatory guidance
- Data management (Oracle Clinical)
At RadPharm, all image interpretation is performed by board-certified physicians, not technologists - and in accordance with the study protocol and industry regulatory standards.
Advantages:
- Our paradigm is to have a designated radiologist read all images on a patient from baseline until completion
- Independent blinded assessments minimize bias
- Time Point Lock Paradigm
- Discordant results are adjudicated for key response variable(s)
- 21 CFR part 11 compliant systems
Benefits:
- Reduced variability
- Accurate, credible trial data
- Maximized statistical power
- Quick results
- Protocol and regulatory compliance
 Oncology Review
RadPharm’s board-certified oncologists provide blinded in-depth Oncology response review. The staff oncologist is trained in the protocol, reviews the clinical data and medical photographs when applicable and assesses response and/or progression in conjunction with review of the radiology response data.
Radiation Therapy QA
Our radiation oncologists provide a quality assurance review of therapy treatment plans created by investigative sites when radiation therapy is used in concert with chemotherapy. This independent central review supports claims of consistency in treatment.
|
